Skip to main content

Table 2 Treatment characteristics at the time of RI

From: A retrospective study of head and neck re-irradiation for patients with recurrent or second primary head and neck cancer: the McGill University experience

  Number Percent
Surgery
 Postoperative RI + systemic therapy 9 33
 Postoperative RI alone 3 11
Definitive RI without surgery   
 RI + systemic therapy 12 45
 RI alone 2 7
Palliative RI 1 4
Concurrent chemotherapy/targeted therapy
 Cisplatin-based 19 70
 Cetuximab 2 7
 None 6 22
  1. Abbreviation: RI re-irradiation